Pharmac will not proceed with proposed changes to how it manages the Options for Investment list
Source: PHARMAC Following feedback, Pharmac has decided not to proceed with a proposal to decline some low-ranked applications on the Options for Investment (OFI) list. In October, Pharmac consulted on a proposal to decline applications that have remained in the lowest-ranked group for more than two years. The aim was to provide greater transparency about … Read more